A study of cetuximab as a third line treatment of metastatic colorectal carcinoma (mCRC), in patients with wild type K-ras gene
Latest Information Update: 06 Oct 2015
At a glance
- Drugs Cetuximab (Primary) ; Irinotecan
- Indications Colon cancer
- Focus Therapeutic Use
Most Recent Events
- 06 Oct 2015 New trial record